Correction to: British Journal of Cancer (2015) 112, 1215–1222. doi:10.1038/bjc.2015.81; published online 12 March 2015
Upon publication of the above paper in the British Journal of Cancer, the authors noted an error in the presentation of a contributing author’s surname. The name of author ‘A-M M Masson’ should have been written as ‘A-M Mes-Masson’. This has been corrected above.
Change history
22 December 2015
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/bjc.2015.81
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
About this article
Cite this article
Koti, M., Siu, A., Clément, I. et al. Erratum: A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer. Br J Cancer 113, 1746 (2015). https://doi.org/10.1038/bjc.2015.459
Published:
Issue Date:
DOI: https://doi.org/10.1038/bjc.2015.459
This article is cited by
-
Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid)
Cancer Chemotherapy and Pharmacology (2020)
